Research blood draw

PROCEDURE11 trials

Conditions

Abdominal CancerBreast CancerBreast CarcinomaCancer of BreastCancer of the PancreasCutaneous AngiosarcomaGlioblastomaMalignant Tumor of Breast

Phase 1

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

TerminatedNCT03422094

Washington University School of MedicineGlioblastoma

Start: 2018-10-31End: 2020-12-31Updated: 2021-10-27

CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome

Active, not recruitingNCT03572764

Washington University School of MedicineMyelodysplastic Syndromes

Start: 2018-12-14End: 2027-03-25Updated: 2025-04-09

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Active, not recruitingNCT03921008

Washington University School of MedicineCutaneous Angiosarcoma

Start: 2019-05-21End: 2028-01-16Updated: 2026-01-21

Phase 2

Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

CompletedNCT03007979

Washington University School of MedicineBreast Cancer, Breast Carcinoma, Cancer of Breast +1

Start: 2017-06-15End: 2023-03-31Updated: 2024-03-20

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

CompletedNCT03449901

Washington University School of MedicineSoft Tissue Sarcoma

Start: 2018-05-09End: 2022-07-08Updated: 2025-12-11

PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma

WithdrawnNCT03598816

Washington University School of MedicineRenal Cell Carcinoma

Start: 2020-08-31End: 2024-05-31Updated: 2020-08-13

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Active, not recruitingNCT04331041

Washington University School of MedicineCancer of the Pancreas, Pancreas Adenocarcinoma, Pancreas Cancer

Start: 2021-08-24End: 2027-04-21Updated: 2026-03-25

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

TerminatedNCT04536077

Washington University School of MedicineCancer of the Pancreas, Pancreas Cancer, Pancreatic Cancer

Start: 2021-08-13End: 2023-11-21Updated: 2024-10-08

Unknown Phase

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

CompletedNCT04553471

Washington University School of MedicineAbdominal Cancer, Pelvic Cancer, Sarcoma +1

Start: 2020-09-22End: 2023-05-04Updated: 2024-08-29

A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors

CompletedNCT05265715

Washington University School of MedicineBreast Cancer

Start: 2022-10-14End: 2024-03-22Updated: 2025-01-08

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

RecruitingNCT05672615

Johns Hopkins UniversityNon-Muscle Invasive Bladder Cancer

Start: 2023-03-21End: 2028-03-31Target: 42Updated: 2025-11-18

Journal of Clinical Oncology2026-01-10

Abstract 1174: Incorporation of multisector analysis into the design of personalized DNA vaccines for patients with newly diagnosed glioblastoma

Cancer Research2024-03-221 citations

Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer

Clinical Cancer Research2023-01-2444 citations

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy

Frontiers in Immunology2022-09-2926 citations

Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade

Cancer Discovery2022-09-2794 citations

Abstract P2-07-01: Blood tumor mutational burden (bTMB) and blood copy number burden (bCNB) by genome-wide circulating tumor DNA (ctDNA) assessment predict outcome and resistance in hormone-receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with CDK4/6 inhibitor (CDK4/6<i>i</i>)

Cancer Research2022-02-15

Abstract PO-112: Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade

Cancer Research2021-11-15

Blood2021-11-058 citations

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology2021-05-209 citations

Abstract PS12-02: Safety and efficacy of an alternative schedule of palbociclib (PAL) in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) and the utility of serum thymidine kinase 1 (sTK1) activity in predicting PAL response

Cancer Research2021-02-15

Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma.

2021-01-2810 citations

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors

Advances in Radiation Oncology2021-01-1084 citations

Abstract P1-19-13: A phase II trial assessing the safety of an alternative dosing schedule of palbociclib (palbo) in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC): Alt Dose Palbo

Cancer Research2020-02-154 citations

Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

Clinical Trials2019-07-01

Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

Cancer Research2019-07-01

A phase II study of ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology2019-05-20

Research blood draw

Sponsors

Conditions

Phase 1

Phase 2

Unknown Phase

Related Papers